Orlando Health Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Orlando Health Ventures/Activity

Orlando Health Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

Becker's Hospital Review profiled Orlando Health Ventures' $20M fund, investment focus, and notable exits including Health Catalyst and Phynd.

Orlando Health's $20M VC arm

Orlando Health Ventures

beckershospitalreview.com

Added recently

3 investments· JUN 2021 – MAR 2026Show all

Investment

Joined Endogenex's oversubscribed $88M Series C to complete its pivotal ReCET clinical study in type 2 diabetes.

Endogenex

Endogenex Orlando Health Ventures

endogenex.comMAR 25, 2026

MAR 25, 2026

Investment

Participated in 410 Medical's $14M Series B-II financing led by Hatteras Venture Partners.

410 Medical

410 MedicalOrlando Health Ventures

ncbiotech.orgMAR 17, 2025

rexhealthventures.com

MAR 17, 2025

Investment

Co-led Quanta Dialysis Technologies' $245M Series D, the largest private funding round for a dialysis device company at the time.

Quanta Dialysis Technologies

Quanta Dialysis TechnologiesOrlando Health Ventures

businesswire.comJUN 23, 2021

JUN 23, 2021

Exit

Portfolio company Phynd Technologies was acquired by symplr.

Phynd Technologies

Phynd TechnologiesOrlando Health Ventures

symplr.comFEB 16, 2021

FEB 16, 2021